Aromatase Inhibitor Therapy and Hair Loss Among Breast Cancer Survivors

    Lisa Gallicchio, Carla Calhoun, Kathy J. Helzlsouer
    Studysummary This study found that female breast cancer survivors using aromatase inhibitors were observed to have a higher likelihood of experiencing hair loss and thinning compared to those not treated with these drugs.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on link.springer.com →
    Discuss this study in the Community →

    Research cited in this study 8

    1. Aromatase Inhibitors Induce Male Pattern Hair Loss in Women Annals of Oncology · 2013
    2. Managing Hair Loss in Midlife Women Maturitas · 2012
    3. Hair: What Is New in Diagnosis and Management? Dermatologic Clinics · 2012
    4. Hormonal Changes in Menopause: Do They Contribute to a Midlife Hair Crisis in Women? British Journal of Dermatology · 2011
    5. Role of Genetics and Sex Steroid Hormones in Male Androgenetic Alopecia and Female Pattern Hair Loss: An Update Australasian Journal of Dermatology · 2011
    6. Gene-Wide Association Study Between the Aromatase Gene (CYP19A1) and Female Pattern Hair Loss British Journal of Dermatology · 2009
    7. The Hair Follicle as an Estrogen Target and Source Endocrine Reviews · 2006
    8. Androgenetic Alopecia in Women Journal of Investigative Dermatology Symposium Proceedings · 2003

    Related research 1

    1. Aromatase-Independent Testosterone Conversion Into Estrogenic Steroids Is Inhibited by a 5α-Reductase Inhibitor The Journal of Steroid Biochemistry and Molecular Biology · 2005